General Information of Drug (ID: DMH7CSQ)

Drug Name
Gavilimomab Drug Info
Synonyms ABX-CBL; CBL-1
Indication
Disease Entry ICD 11 Status REF
Graft-versus-host disease 4B24 Phase 2/3 [1]
Cross-matching ID
TTD Drug ID
DMH7CSQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Basigin (BSG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
[131I]-Metuximab DM4VWXI Liver cancer 2C12 Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Basigin (BSG) TT5UJWD BASI_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT00035880) Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 38221).
3 Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):435-44.